EUVIMEDEUVIMED entdecken
Validierungsstudie

Validity of High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Mobile Tongue Cancer in Terms of the Acute Mucosal Reaction

Hironori Akiyama, Ken Yoshida, Tadayuki Kotsuma, Koji Masui, Tadashi Takenaka, Manabu Kano, Fumiaki Isohashi, Yuji Seo, Taiju Shimbo, Naoya Murakami, Yui Mori, Shinya Kotaki und 10 weitere

The Kurume Medical Journal · 2024

DOI: 10.2739/kurumemedj.ms7112003 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift The Kurume Medical Journal, 2024. Verfasst von Hironori Akiyama und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Radiology, Osaka Dental University. Hauptthemen laut MEDLINE: Brachytherapy, Tongue Neoplasms. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The present study investigated the acute mucosal reaction (AMR) after high-dose-rate interstitial brachytherapy at 54 Gy/9 fractions (HDR54) as monotherapy administered twice a day for tongue cancer in 13 patients, and attempted to validate HDR54 by comparing the AMR with that of our previously reported HDR at 60 Gy/10 fractions (HDR60), and low-dose-rate interstitial brachytherapy at approximately 70 Gy (LDR70). METHODS: The European Organization for Research on Treatment of Cancer/ Radiation Therapy Oncology Group scoring system with modifications (score: 1-4.5) was used to evaluate AMR. The time courses of the AMR scores of HDR54 were recorded. The time courses of the AMR of HDR54, HDR 60, and LDR70 were each divided into 6 phases and compared. RESULTS: The number of cases in the HDR54 group with a lower score (1-2) at the time of the initial response was significantly higher (12 cases) than those in the HDR60 group (1 case) (p=0.0077) and LDR70 group (1 case) (p=0.0077). In the HDR54 group, the time between the end of treatment and appearance of the first response was significantly longer (median: 3 days) than those in the HDR60 group (median: 1 day) (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyTongue NeoplasmsHumansMiddle AgedMaleFemaleAgedRadiotherapy DosageTreatment Outcome

Stichwörter der Autor:innen

54 Gy/9 fractionsacute mucosal reactionhigh-dose-rate interstitial brachytherapymobile tongue cancer

Autor:innen und Institutionen

  • Department of Oral Radiology, Osaka Dental University.
  • Department of Radiology, Kansai Medical University Medical Center.
  • Department of Radiation Therapy, Osaka Rosai Hospital.
  • Department of Radiology, Kyoto Prefectural University of Medicine.
  • Department of Oral and Maxillofacial Surgery, National Hospital Organization Osaka National Hospital.
  • Department of Radiation Oncology, Nara Medical University.

Zitieren

APA

Akiyama, H., Yoshida, K., Kotsuma, T., Masui, K., Takenaka, T., Kano, M., Isohashi, F., Seo, Y., Shimbo, T., Murakami, N., Mori, Y., Kotaki, S., Yoshimoto, H., Tanaka, E., Tselis, N., Takácsi-Nagy, Z., Yamazaki, H., Nakamura, S., Tanigawa, N., …, & Ariji, Y. (2024). Validity of High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Mobile Tongue Cancer in Terms of the Acute Mucosal Reaction. The Kurume Medical Journal. https://doi.org/10.2739/kurumemedj.ms7112003

Vancouver

Akiyama H, Yoshida K, Kotsuma T, Masui K, Takenaka T, Kano M, et al. Validity of High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Mobile Tongue Cancer in Terms of the Acute Mucosal Reaction. The Kurume Medical Journal. 2024. doi:10.2739/kurumemedj.ms7112003

BibTeX
@article{Akiyama2024,
  author = {Akiyama, Hironori and Yoshida, Ken and Kotsuma, Tadayuki and Masui, Koji and Takenaka, Tadashi and Kano, Manabu and Isohashi, Fumiaki and Seo, Yuji and Shimbo, Taiju and Murakami, Naoya and Mori, Yui and Kotaki, Shinya and Yoshimoto, Hitoshi and Tanaka, Eiichi and Tselis, Nikolaos and Takácsi-Nagy, Zoltán and Yamazaki, Hideya and Nakamura, Satoaki and Tanigawa, Noboru and Shimizutani, Kimishige and Ogawa, Kazuhiko and Ariji, Yoshiko},
  title = {Validity of High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Mobile Tongue Cancer in Terms of the Acute Mucosal Reaction},
  journal = {The Kurume Medical Journal},
  year = {2024},
  doi = {10.2739/kurumemedj.ms7112003}
}
Kostenlos starten →